<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN"
                           "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer Berlin Heidelberg</PublisherName>
    <PublisherLocation>Berlin/Heidelberg</PublisherLocation>
    <PublisherImprintName>Springer</PublisherImprintName>
  </PublisherInfo>
  <Journal OutputMedium="All">
    <JournalInfo JournalProductType="NonStandardArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>66</JournalID>
      <JournalDOI>10.1007/66.1439-099X</JournalDOI>
      <JournalPrintISSN>0179-7158</JournalPrintISSN>
      <JournalElectronicISSN>1439-099X</JournalElectronicISSN>
      <JournalTitle>Strahlentherapie und Onkologie</JournalTitle>
      <JournalSubTitle>Journal of Radiation Oncology, Biology, Physics</JournalSubTitle>
      <JournalAbbreviatedTitle>Strahlenther Onkol</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="SCH" Type="Primary">Medicine &amp; Public Health</JournalSubject>
        <JournalSubject Code="SCH29056" Priority="1" Type="Secondary">Radiotherapy</JournalSubject>
        <JournalSubject Code="SCH43008" Priority="2" Type="Secondary">Oncology</JournalSubject>
        <SubjectCollection Code="SC11">Medicine</SubjectCollection>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume OutputMedium="All">
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>191</VolumeIDStart>
        <VolumeIDEnd>191</VolumeIDEnd>
        <VolumeIssueCount>12</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular" OutputMedium="All">
        <IssueInfo IssueType="Regular" TocLevels="0">
          <IssueIDStart>6</IssueIDStart>
          <IssueIDEnd>6</IssueIDEnd>
          <IssueArticleCount>12</IssueArticleCount>
          <IssueHistory>
            <OnlineDate>
              <Year>2015</Year>
              <Month>5</Month>
              <Day>30</Day>
            </OnlineDate>
            <PrintDate>
              <Year>2015</Year>
              <Month>5</Month>
              <Day>29</Day>
            </PrintDate>
            <CoverDate>
              <Year>2015</Year>
              <Month>6</Month>
            </CoverDate>
            <PricelistYear>2015</PricelistYear>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>
            <CopyrightYear>2015</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="s00066-015-0824-4" OutputMedium="All">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>824</ArticleID>
            <ArticleDOI>10.1007/s00066-015-0824-4</ArticleDOI>
            <ArticleSequenceNumber>6</ArticleSequenceNumber>
            <ArticleTitle Language="En">Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer</ArticleTitle>
            <ArticleSubTitle Language="En">Results of a prospective study</ArticleSubTitle>
            <ArticleTitle Language="De">Residuale Defizite in der Lebensqualität ein Jahr nach intensitätsmodulierter Strahlentherapie bei Patienten mit lokal fortgeschrittenen Kopf-Hals-Tumoren</ArticleTitle>
            <ArticleSubTitle Language="De">Ergebnisse einer prospektiven Studie</ArticleSubTitle>
            <ArticleCategory>Original Article</ArticleCategory>
            <ArticleFirstPage>501</ArticleFirstPage>
            <ArticleLastPage>510</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2015</Year>
                <Month>1</Month>
                <Day>28</Day>
              </RegistrationDate>
              <Received>
                <Year>2014</Year>
                <Month>12</Month>
                <Day>3</Day>
              </Received>
              <Accepted>
                <Year>2015</Year>
                <Month>1</Month>
                <Day>28</Day>
              </Accepted>
              <OnlineDate>
                <Year>2015</Year>
                <Month>3</Month>
                <Day>8</Day>
              </OnlineDate>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>
              <CopyrightYear>2015</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <Prefix>PD Dr. med.</Prefix>
                  <GivenName>Silke</GivenName>
                  <FamilyName>Tribius</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>+49 40 7410 56140/54033</Phone>
                  <Email>tribius@uke.uni-hamburg.de</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Marieclaire</GivenName>
                  <FamilyName>Raguse</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Christian</GivenName>
                  <FamilyName>Voigt</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff3">
                <AuthorName DisplayOrder="Western">
                  <Prefix>PD Dr. med.</Prefix>
                  <GivenName>Adrian</GivenName>
                  <FamilyName>Münscher</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff4">
                <AuthorName DisplayOrder="Western">
                  <Prefix>PD. Dr. med. Dr. dent.</Prefix>
                  <GivenName>Alexander</GivenName>
                  <FamilyName>Gröbe</FamilyName>
                  <Degrees>PD Dr. med. Dr. dent.</Degrees>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff2">
                <AuthorName DisplayOrder="Western">
                  <Prefix>PD Dr. med.</Prefix>
                  <GivenName>Cordula</GivenName>
                  <FamilyName>Petersen</FamilyName>
                  <Degrees>Prof. Dr. med.</Degrees>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff2">
                <AuthorName DisplayOrder="Western">
                  <Prefix>PD Dr. med.</Prefix>
                  <GivenName>Andreas</GivenName>
                  <FamilyName>Krüll</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff5">
                <AuthorName DisplayOrder="Western">
                  <Prefix>PD Dr. phil.</Prefix>
                  <GivenName>Corinna</GivenName>
                  <FamilyName>Bergelt</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff6">
                <AuthorName DisplayOrder="Western">
                  <Prefix>Prof. Dr.</Prefix>
                  <GivenName>Susanne</GivenName>
                  <FamilyName>Singer</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Department of Radiation Oncology</OrgDivision>
                <OrgName>University Medical Center Hamburg–Eppendorf</OrgName>
                <OrgAddress>
                  <Street>Martinistr. 52</Street>
                  <Postcode>20246</Postcode>
                  <City>Hamburg</City>
                  <Country>Germany</Country>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff2">
                <OrgDivision>Department of Radiation Oncology</OrgDivision>
                <OrgName>University Medical Center Hamburg–Eppendorf</OrgName>
                <OrgAddress>
                  <City>Hamburg</City>
                  <Country>Germany</Country>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff3">
                <OrgDivision>Department of Otorhinolaryngology and Head and Neck Surgery</OrgDivision>
                <OrgName>University Medical Center Hamburg-Eppendorf</OrgName>
                <OrgAddress>
                  <City>Hamburg</City>
                  <Country>Germany</Country>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff4">
                <OrgDivision>Department of Maxillofacial Surgery</OrgDivision>
                <OrgName>University Medical Center Hamburg-Eppendorf</OrgName>
                <OrgAddress>
                  <City>Hamburg</City>
                  <Country>Germany</Country>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff5">
                <OrgDivision>Department of Medical Psychology</OrgDivision>
                <OrgName>University Medical Center Hamburg-Eppendorf</OrgName>
                <OrgAddress>
                  <City>Hamburg</City>
                  <Country>Germany</Country>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff6">
                <OrgDivision>Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI)</OrgDivision>
                <OrgName>University Medical Center Mainz</OrgName>
                <OrgAddress>
                  <City>Mainz</City>
                  <Country>Germany</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En" OutputMedium="All">
              <Heading>Abstract</Heading>
              <AbstractSection ID="ASec1">
                <Heading>Purpose</Heading>
                <Para>Patients with locally advanced head and neck cancer (LAHNC) undergo life-changing treatments that can seriously affect quality of life (QoL). This prospective study examined the key QoL domains during the first year after intensity-modulated radiotherapy (IMRT) and identified predictors of these changes in order to improve patient outcomes.</Para>
              </AbstractSection>
              <AbstractSection ID="ASec2">
                <Heading>Patients and methods</Heading>
                <Para>A consecutive series of patients with LAHNC completed the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core module (QLQ-C30) and the HNC-specific QLQ-HN35 before (t0) and at the end (t1) of definitive or adjuvant IMRT, then at 6–8 weeks (t2), 6 months (t3), and 1 year (t4) after IMRT.</Para>
              </AbstractSection>
              <AbstractSection ID="ASec3">
                <Heading>Results</Heading>
                <Para>Patients (<Emphasis Type="Italic">n</Emphasis> = 111) completing questionnaires at all five time points were included (baseline response rate: 99 %; dropout rate between t0 and t4: 5 %). QoL deteriorated in all domains during IMRT and improved slowly during the first year thereafter. Many domains recovered to baseline values after 1 year but problems with smelling and tasting, dry mouth, and sticky saliva remained issues at this time. Increases in problems with sticky saliva were greater after 1 year in patients with definitive versus adjuvant IMRT (F = 3.5, <Emphasis Type="Italic">P</Emphasis> = 0.05).</Para>
              </AbstractSection>
              <AbstractSection ID="ASec4">
                <Heading>Conclusion</Heading>
                <Para>QoL in patients with LAHNC receiving IMRT takes approximately 1 year to return to baseline; some domains remain compromised after 1 year. Although IMRT aims to maintain function and QoL, patients experience long-term dry mouth and sticky saliva, particularly following definitive IMRT. Patients should be counseled at the start of therapy to reduce disappointment with the pace of recovery.</Para>
              </AbstractSection>
            </Abstract>
            <Abstract ID="Abs2" Language="De" OutputMedium="All">
              <Heading>Zusammenfassung</Heading>
              <AbstractSection ID="ASec5">
                <Heading>Hintergrund</Heading>
                <Para>Die Therapie von Patienten mit lokal fortgeschrittenen Kopf-Hals-Tumoren (LFKHT) geht mit einschneidenden Veränderungen einher und beeinflusst die Lebensqualität (LQ) erheblich. Diese prospektive Studie untersucht die LQ während des ersten Jahres nach intensitätsmodulierter Strahlentherapie (IMRT) und hat Prädiktoren dieser Veränderungen herausgearbeitet, um Therapieergebnisse verbessern zu können.</Para>
              </AbstractSection>
              <AbstractSection ID="ASec6">
                <Heading>Patienten und Methoden</Heading>
                <Para>Patienten mit LFKHT füllten Lebensqualitätsfragebögen der European Organisation for Research and Treatment of Cancer (EORTC) aus; Hauptfragebogen (QLQ-C30) und Kopf-Hals-Tumor-Fragebogen (QLQ-HN35) jeweils vor definitiver oder adjuvanter IMRT (t0), am Ende der IMRT (t1), nach weiteren 6–8 Wochen (t2), 6 Monaten (t3) und nach 1 Jahr (t4).</Para>
              </AbstractSection>
              <AbstractSection ID="ASec7">
                <Heading>Ergebnisse</Heading>
                <Para>Insgesamt haben 111 Patienten zu allen fünf Zeitpunkten die Fragebögen ausgefüllt und wurden in die Studie eingeschlossen (Responserate t0: 99%; Ausfallrate t0–t4: 5 %). Während der IMRT verschlechterten sich alle Domänen der LQ und besserten sich langsam über das erste Folgejahr. Viele Lebensqualitätswerte kehrten zum Ausgangsniveau zurück, während Probleme mit Riechen und Schmecken, trockener Mund und klebriger Speichel problematisch blieben. Probleme mit klebrigem Speichel wurden von Patienten nach definitiver IMRT häufiger berichtet als von Patienten nach adjuvanter Therapie (F = 3,5; <Emphasis Type="Italic">P</Emphasis> = 0,05).</Para>
              </AbstractSection>
              <AbstractSection ID="ASec8">
                <Heading>Schlussfolgerung</Heading>
                <Para>Nach einer IMRT dauert es bei Patienten mit Kopf-Hals-Tumoren bis zu 1 Jahr bis die LQ wieder ihr Ausgangsniveau erreicht; einige Domänen bleiben auch noch nach 1 Jahr darunter. Obwohl es Ziel der IMRT ist, Funktion und LQ zu erhalten, bleiben trockener Mund und klebriger Speichel teilweise als Langzeiteffekte bestehen, insbesondere bei Patienten nach primärer IMRT. Patienten sollten diesbezüglich vor Beginn der Therapie aufgeklärt werden, um ihnen Unzufriedenheit mit der Geschwindigkeit der Rekonvaleszenz zu ersparen.</Para>
              </AbstractSection>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>Rehabilitation</Keyword>
              <Keyword>Xerostomia</Keyword>
              <Keyword>Toxicity</Keyword>
              <Keyword>Taste sense</Keyword>
              <Keyword>Sense of smell</Keyword>
            </KeywordGroup>
            <KeywordGroup Language="De">
              <Heading>Schlüsselwörter</Heading>
              <Keyword>Rehabilitation</Keyword>
              <Keyword>Xerostomie</Keyword>
              <Keyword>Toxizität</Keyword>
              <Keyword>Geschmackssinn</Keyword>
              <Keyword>Geruchssinn</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>S. Tribius and M. Raguse contributed equally to this work.</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <Body>
            <Para>Patients with newly diagnosed head and neck cancer (HNC) face many issues that can impact on their quality of life (QoL). Treatment for locally advanced HNC (LAHNC) is usually multimodal, involving surgery, radiotherapy, and systemic therapy. Over recent years treatment has become more intensive and is associated with a greater toxicity burden [<CitationRef CitationID="CR1">1</CitationRef>–<CitationRef CitationID="CR3">3</CitationRef>]. Side effects associated with treatment for HNC can have a profound effect on everyday activities. Surgery, if required, may leave patients with facial disfiguration depending on size and location of the tumor [<CitationRef CitationID="CR4">4</CitationRef>]. Finally, radiotherapy can affect structures adjacent to the tumor, which may result in xerostomia, dysphagia, trismus, and osteoradionecrosis [<CitationRef CitationID="CR5">5</CitationRef>, <CitationRef CitationID="CR6">6</CitationRef>].</Para>
            <Para>Assessing QoL is becoming increasingly important. Recent guidelines state that health-related QoL issues are of paramount importance: “Tumors affect basic physiological functions (i.e. the ability to chew, swallow, and breathe), senses (taste, smell, and hearing), and uniquely human characteristics (i.e. appearance and voice)” [<CitationRef CitationID="CR2">2</CitationRef>].</Para>
            <Para>It has been shown that sparing both parotid glands during intensity-modulated radiation therapy (IMRT) reduces the incidence of xerostomia, dysphagia, and the number of patients requiring a percutaneous gastrostomy significantly [<CitationRef CitationID="CR7">7</CitationRef>]. IMRT was developed with the aim of reducing side effects of radiotherapy without compromising oncological efficacy [<CitationRef CitationID="CR8">8</CitationRef>]. Studies have shown that this aim has been achieved [<CitationRef CitationID="CR9">9</CitationRef>]; however, information is still lacking regarding the length of time needed by patients to completely recover some aspects of QoL. Healthcare practitioners armed with an understanding of which aspects of QoL are slow to recover may be better able to council patients as to what to expect in the future and provide additional support after treatment, potentially improving QoL. Likewise, a better understanding is needed of why some patients recover more easily than others; therefore, predictors of change in QoL should be explored in more detail.</Para>
            <Para>The present study examined whether QoL in patients with LAHNC recovers to baseline levels within 1 year after IMRT. We also investigated which QoL areas improve and deteriorate during and after treatment, and what factors are related to these changes.</Para>
            <Section1 ID="Sec1">
              <Heading>Patients and methods</Heading>
              <Section2 ID="Sec2">
                <Heading>Study design and sampling</Heading>
                <Para>Patients with LAHNC (nonmetastatic) who were treated with curative-intent IMRT (60–70 Gy at 2 Gy/fraction), either definitive or adjuvant, were eligible for this prospective study. Platinum-based chemotherapy (100 mg/m² on days 1, 22, and 43 or 30 mg/m² weekly) was administered [<CitationRef CitationID="CR2">2</CitationRef>, <CitationRef CitationID="CR10">10</CitationRef>, <CitationRef CitationID="CR11">11</CitationRef>]. Radiation dose was prescribed according to ICRU report 83. Sensitive structures were contoured and a margin of 2 mm applied. Depending on tumor site and nodal disease the dose constraints applied to the parotid glands and oral cavity/pharyngeal structures/larynx were ≤ 20 Gy and ≤ 30–36 Gy, respectively.</Para>
                <Para>Eligible patients were approached consecutively by the radiation oncologist. Questionnaires were completed during scheduled visits. Approval was obtained from the local ethics committee. All patients provided written informed consent.</Para>
              </Section2>
              <Section2 ID="Sec3">
                <Heading>Endpoints</Heading>
                <Para>QoL was measured before IMRT (t0), at the end of IMRT (t1), 6–8 weeks (t2), 6 months (t3), and 1 year after IMRT (t4). Questionnaires were self-completed in the physician’s office at these times. The German-language version of the European Organisation for Research and Treatment of Cancer (EORTC) 30-item Quality of Life Core Questionnaire (QLQ-C30)[<CitationRef CitationID="CR12">12</CitationRef>] and the 35-item Head and Neck module (HN35) [<CitationRef CitationID="CR12">12</CitationRef>] were used. The QLQ-C30 consists of a global health scale and five functioning scales (Emotional, Physical, Cognitive, Social, and Role), as well as three multi-item and six single-item symptom scales (Fatigue, Pain, Nausea and vomiting, Dyspnea, Insomnia, Appetite loss, Constipation, Diarrhea, and Financial difficulties). The HN35 includes seven head and neck-specific multi-item symptom scales (Pain in the mouth, Swallowing, Senses, Speech, Social eating, Social contact, and Sexuality), six single-item scales (Problems with teeth, Problems opening mouth, Dry mouth, Sticky saliva, Coughing, and Feeling ill) and five yes/no items (Use of painkillers, Nutritional supplements, Feeding tube, Weight loss, and Weight gain).</Para>
                <Para>A score of 100 indicates perfect QoL on the functional scales, whereas for the symptom scales a score of 100 indicates a heavy burden. Score differences of 10 points or more between patient subgroups are considered to be clinically relevant [<CitationRef CitationID="CR13">13</CitationRef>]. The reliability and validity of the C30 and HN35 scales are considered acceptable [<CitationRef CitationID="CR14">14</CitationRef>, <CitationRef CitationID="CR15">15</CitationRef>].</Para>
                <Para>Toxicity (dysphagia, mucositis, and xerostomia) was rated at all assessment points between t0 and t4 using the Radiation Therapy Oncology Group (RTOG) toxicity criteria. Ratings were performed by the radiation oncologist (blinded to the QoL scores).</Para>
                <Para>Weight and type of diet (parenteral, enteral, or oral) were documented.</Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec4">
              <Heading>Data analysis</Heading>
              <Para>Mean scores (± standard deviation) for the C30 and HN35 were calculated as defined in the EORTC manual [<CitationRef CitationID="CR16">16</CitationRef>], with a scale only being computed if the patient had completed at least half of its items. The distribution of the data was investigated visually. Changes over time were analyzed by calculating pairwise absolute differences between the measurement time points using matched-pair <Emphasis Type="Italic">t</Emphasis> tests.</Para>
              <Para>An exploratory investigation of potential predictors of differences between baseline and 1 year after IMRT in key QoL domains (Senses, Dry mouth, and Sticky saliva) was performed using a multivariate generalized linear model analysis of variance with repeated measures. The selection of predictor variables to be tested was made <Emphasis Type="Italic">a priori</Emphasis> based on evidence from the literature and clinical experience. The same predictors were included in all models. Variables entered simultaneously were sequence of IMRT (definitive vs adjuvant treatment), tumor site (oral cavity vs other), and age (years).</Para>
              <Para>Statistical analyses were performed using STATA version 10 (StataCorp, College Station, TX, USA).</Para>
            </Section1>
            <Section1 ID="Sec5">
              <Heading>Results</Heading>
              <Section2 ID="Sec6">
                <Heading>Patients</Heading>
                <Para>Patient enrollment began in March 2009 and the last patient included in this analysis was seen in March 2013. A total of 145 patients were included at baseline. One year after the baseline assessment, 115 patients (79 %) were seen again; 28 patients (19 %) had died, 1 patient (1 %) was lost to follow-up, and 1 patient (1 %) did not complete a QoL questionnaire. QoL measurements at all four time points were available for 111 patients (95 % of those still alive 1 year after baseline). All of the analyses described herein are based on these 111 patients. Baseline characteristics of patients are shown in Table <InternalRef RefID="Tab1">1</InternalRef>.<Table Float="Yes" ID="Tab1">
                    <Caption Language="En">
                      <CaptionNumber>Table 1</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Baseline characteristics (<Emphasis Type="Italic">n</Emphasis> = 111)</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <tgroup cols="2">
                      <colspec align="left" colname="c1" colnum="1"/>
                      <colspec align="left" colname="c2" colnum="2"/>
                      <thead>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Characteristic</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>Patients, <Emphasis Type="Italic">n</Emphasis> (%)</SimplePara>
                          </entry>
                        </row>
                      </thead>
                      <tbody>
                        <row>
                          <entry align="left" nameend="c2" namest="c1">
                            <SimplePara>Sex, <Emphasis Type="Italic">n</Emphasis> (%)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Male</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>78 (70)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Female</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>33 (30)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Age at baseline, years</SimplePara>
                          </entry>
                          <entry align="left" colname="c2"/>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>&lt; 50</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>19 (17)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>50–59</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>35 (32)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>60–69</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>43 (39)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>≥ 70</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>14 (13)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" nameend="c2" namest="c1">
                            <SimplePara>Karnofsky performance score</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>100</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>9 (8)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>90</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>38 (34)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>80</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>30 (27)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>70</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>30 (27)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>60</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>3 (3)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>50</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>1 (1)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" nameend="c2" namest="c1">
                            <SimplePara>Tumor stage</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>T1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>22 (20)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>T2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>33 (30)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>T3</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>25 (23)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>T4</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>25 (23)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Tx</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>6 (5)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" nameend="c2" namest="c1">
                            <SimplePara>Nodal stage</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>N0</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>24 (22)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>N1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>22 (20)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>N2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>60 (54)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>N3</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>5 (5)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" nameend="c2" namest="c1">
                            <SimplePara>Treatment</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>RT only</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>5 (5)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Definitive CRT</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>28 (25)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Adjuvant RT</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>47 (42)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Adjuvant CRT</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>31 (28)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" nameend="c2" namest="c1">
                            <SimplePara>Tumor site</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Oral cavity</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>35 (32)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Oropharynx</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>41 (37)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Hypopharynx/larynx</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>22 (20)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Nasopharynx</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>5 (5)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Nasal</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>4 (4)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Unknown primary</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>4 (4)</SimplePara>
                          </entry>
                        </row>
                      </tbody>
                    </tgroup>
                    <tfooter>
                      <SimplePara>
                        <Emphasis Type="Italic">CRT</Emphasis> chemoradiotherapy, <Emphasis Type="Italic">RT</Emphasis> radiotherapy.</SimplePara>
                    </tfooter>
                  </Table>
                </Para>
              </Section2>
              <Section2 ID="Sec7">
                <Heading>Treatment</Heading>
                <Para>Twenty-eight patients (25 %) had received definitive chemoradiotherapy, 47 patients (42 %) had adjuvant radiotherapy, 31 (28 %) had adjuvant chemoradiotherapy, and 5 patients (5 %) had radiotherapy only. In terms of parotid sparing, 39 patients (35 %) received &lt; 26 Gy to both parotids, 62 (56 %) received &lt; 26 Gy to one parotid, and 9 patients (8 %) received &gt; 26 Gy to both parotids; this information was not available for 1 patient.</Para>
              </Section2>
              <Section2 ID="Sec8">
                <Heading>Changes in QoL over time</Heading>
                <Para>QoL deteriorated during IMRT, resulting in statistically significantly lower scores at the end of treatment compared with baseline on all C30 functioning scales, and higher scores for most symptom scales, indicating a greater degree of cancer-related symptoms (Table <InternalRef RefID="Tab2">2</InternalRef>). A similar pattern was observed for the HN35, with statistically significantly higher scores at the end of treatment for all domains except Problems with teeth (Table <InternalRef RefID="Tab2">2</InternalRef>; Fig. <InternalRef RefID="Fig1">1</InternalRef>). Marked increases (&gt; 30 points) were observed at the end of IMRT compared with baseline in domains such as Swallowing (+ 37), Senses (+ 40), Social eating (+ 35), Dry mouth (+ 35), Sticky saliva (+ 51), and Feeding tube (+ 49), indicating clinically significantly poorer QoL at this time (Table <InternalRef RefID="Tab2">2</InternalRef>).<Figure Category="Standard" Float="Yes" ID="Fig1">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 1</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Changes in European Organisation for Research and Treatment of Cancer quality of life questionnaire Head and Neck Module scores over time before IMRT (t0), at the end of IMRT (t1), 6–8 weeks after IMRT (t2), 6 months after IMRT (t3), and 1 year after baseline (t4) in patients with head and neck cancer (<Emphasis Type="Italic">n</Emphasis> = 111). Unadjusted mean scores. (<Emphasis Type="Italic">IMRT</Emphasis> intensity modulated radiotherapy, <Emphasis Type="Italic">RT</Emphasis> radiotherapy, <Emphasis Type="Italic">t</Emphasis> timepoint)</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO1">
                      <ImageObject Color="BlackWhite" FileRef="MediaObjects/66_2015_824_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
                    </MediaObject>
                  </Figure>
                  <Table Float="Yes" ID="Tab2">
                    <Caption Language="En">
                      <CaptionNumber>Table 2</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Evolution of general QoL, measured using the EORTC QLQ-C30 and HN35 during and after treatment. Values in bold are changes of ≥ 10 points. Positive changes imply improved function or more symptoms over time. Negative changes imply worsened function or fewer symptoms over time</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <tgroup cols="10">
                      <colspec align="left" colname="c1" colnum="1"/>
                      <colspec align="left" colname="c2" colnum="2"/>
                      <colspec align="left" colname="c3" colnum="3"/>
                      <colspec align="left" colname="c4" colnum="4"/>
                      <colspec align="left" colname="c5" colnum="5"/>
                      <colspec align="left" colname="c6" colnum="6"/>
                      <colspec align="left" colname="c7" colnum="7"/>
                      <colspec align="left" colname="c8" colnum="8"/>
                      <colspec align="left" colname="c9" colnum="9"/>
                      <colspec align="left" colname="c10" colnum="10"/>
                      <thead>
                        <row>
                          <entry align="left" colname="c1" morerows="1">
                            <SimplePara>Mean (SD) scale score<Superscript>a</Superscript>
                            </SimplePara>
                          </entry>
                          <entry align="left" nameend="c6" namest="c2">
                            <SimplePara>Timepoint</SimplePara>
                          </entry>
                          <entry align="left" colname="c7" morerows="1">
                            <SimplePara>∆t0–t1<Superscript>b</Superscript>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8" morerows="1">
                            <SimplePara>
                              <Emphasis Type="Italic">P</Emphasis>
                              <Subscript>t0–t1</Subscript>
                              <Superscript>c</Superscript>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c9" morerows="1">
                            <SimplePara>∆t0–t4<Superscript>b</Superscript>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c10" morerows="1">
                            <SimplePara>
                              <Emphasis Type="Italic">P</Emphasis>
                              <Subscript>t0–t4</Subscript>
                              <Superscript>c</Superscript>
                            </SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>t0</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>t1</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>t2</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>t3</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>t4</SimplePara>
                          </entry>
                        </row>
                      </thead>
                      <tbody>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>
                              <Emphasis Type="Bold">QLQ-C30</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c2" morerows="1"/>
                          <entry align="left" colname="c3" morerows="1"/>
                          <entry align="left" colname="c4" morerows="1"/>
                          <entry align="left" colname="c5" morerows="1"/>
                          <entry align="left" colname="c6" morerows="1"/>
                          <entry align="left" colname="c7" morerows="1"/>
                          <entry align="left" colname="c8" morerows="1"/>
                          <entry align="left" colname="c9" morerows="1"/>
                          <entry align="left" colname="c10" morerows="1"/>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>
                              <Emphasis Type="Italic">Functioning scales</Emphasis>
                            </SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Physical functioning</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>77 (23)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>60 (24)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>72 (21)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>77 (22)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>78 (23)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">− 17</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>1</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.73</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Role functioning</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>58 (37)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>36 (33)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>55 (30)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>63 (30)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>68 (30)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">− 21</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>
                              <Emphasis Type="Bold">11</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.02</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Emotional functioning</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>59 (29)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>46 (25)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>60 (26)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>67 (25)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>67 (24)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">− 13</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>7</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.02</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Cognitive functioning</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>79 (26)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>67 (26)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>79 (22)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>78 (22)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>79 (22)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">− 12</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>0</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.86</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Social functioning</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>60 (34)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>38 (30)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>56 (29)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>63 (30)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>72 (27)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">− 22</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>
                              <Emphasis Type="Bold">12</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Global health status</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>50 (24)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>35 (23)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>54 (21)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>59 (21)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>64 (21)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">− 15</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>
                              <Emphasis Type="Bold">14</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" nameend="c10" namest="c1">
                            <SimplePara>
                              <Emphasis Type="Italic">Symptom scales</Emphasis>
                            </SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Fatigue</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>41 (29)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>67 (26)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>48 (26)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>39 (25)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>38 (26)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">26</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>− 2</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.46</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Nausea and vomiting</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>7 (15)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>35 (33)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>16 (24)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>6 (12)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>4 (10)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">29</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>− 3</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.11</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Pain</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>38 (34)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>57 (34)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>32 (30)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>26 (28)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>27 (29)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">19</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>
                              <Emphasis Type="Bold">− 11</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Dyspnea</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>25 (30)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>33 (31)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>26 (31)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>22 (29)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>23 (29)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>8</SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>− 2</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.55</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Insomnia</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>38 (34)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>54 (35)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>37 (34)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>36 (34)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>34 (33)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">15</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>− 4</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.32</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Appetite loss</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>27 (36)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>69 (36)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>39 (37)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>27 (34)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>24 (33)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">41</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>− 2</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.60</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Constipation</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>11 (24)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>33 (36)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>20 (29)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>13 (26)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>12 (24)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">22</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>1</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.83</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Diarrhea</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>13 (25)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>21 (32)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>13 (24)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>8 (19)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>10 (23)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>8</SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>0.03</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>− 4</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.21</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Financial difficulties</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>32 (36)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>39 (35)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>35 (35)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>32 (34)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>31 (35)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>8</SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>0.02</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>− 1</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.75</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>
                              <Emphasis Type="Bold">HN35</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c2" morerows="1"/>
                          <entry align="left" colname="c3" morerows="1"/>
                          <entry align="left" colname="c4" morerows="1"/>
                          <entry align="left" colname="c5" morerows="1"/>
                          <entry align="left" colname="c6" morerows="1"/>
                          <entry align="left" colname="c7" morerows="1"/>
                          <entry align="left" colname="c8" morerows="1"/>
                          <entry align="left" colname="c9" morerows="1"/>
                          <entry align="left" colname="c10" morerows="1"/>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>
                              <Emphasis Type="Italic">Multi-item symptoms scales</Emphasis>
                            </SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Pain in the mouth</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>29 (26)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>58 (29)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>31 (23)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>23 (23)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>20 (23)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">29</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>− 9</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Swallowing</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>33 (32)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>70 (24)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>41 (30)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>35 (30)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>29 (29)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">37</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>− 4</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.22</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Senses</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>21 (28)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>61 (27)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>45 (30)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>40 (30)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>35 (29)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">40</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>
                              <Emphasis Type="Bold">14</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Speech</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>33 (30)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>61 (30)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>36 (28)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>32 (28)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>28 (26)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">28</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>− 5</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.11</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Social eating</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>33 (31)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>68 (29)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>47 (33)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>40 (34)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>33 (30)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">35</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>0</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.93</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Social contact</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>17 (20)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>35 (28)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>20 (21)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>18 (22)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>14 (18)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">17</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>− 3</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.15</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Sexuality</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>45 (39)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>70 (37)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>50 (38)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>51 (38)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>40 (38)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">22</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>− 7</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.16</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" nameend="c10" namest="c1">
                            <SimplePara>
                              <Emphasis Type="Italic">Single-item symptom scales</Emphasis>
                            </SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Problems with teeth</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>25 (35)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>28 (35)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>23 (33)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>23 (31)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>31 (37)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>5</SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>0.29</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>3</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.40</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Problems opening mouth</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>33 (38)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>63 (39)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>41 (37)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>37 (37)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>35 (36)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">29</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>3</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.51</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Dry mouth</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>33 (33)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>68 (35)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>69 (34)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>68 (30)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>60 (30)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">35</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>
                              <Emphasis Type="Bold">28</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Sticky saliva</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>35 (36)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>86 (26)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>64 (35)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>53 (35)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>50 (35)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">51</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>
                              <Emphasis Type="Bold">15</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Coughed</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>38 (32)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>65 (32)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>39 (31)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>40 (32)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>39 (28)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">28</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>2</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.69</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Felt ill</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>43 (33)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>68 (31)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>38 (30)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>29 (28)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>25 (26)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">26</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>
                              <Emphasis Type="Bold">− 18</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" nameend="c10" namest="c1">
                            <SimplePara>
                              <Emphasis Type="Italic">Additional items</Emphasis>
                            </SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Painkillers</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>51 (50)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>74 (44)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>49 (50)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>34 (48)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>24 (43)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">23</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>
                              <Emphasis Type="Bold">− 27</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Nutritional supplements</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>18 (39)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>46 (50)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>44 (50)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>31 (46)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>25 (44)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">29</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>7</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.21</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Feeding tube</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>25 (43)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>73 (45)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>60 (49)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>41 (49)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>29 (46)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">49</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>4</SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>0.44</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Weight loss</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>59 (49)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>77 (42)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>50 (50)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>30 (46)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>16 (37)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">18</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>
                              <Emphasis Type="Bold">− 43</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Weight gain</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>15 (36)</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>5 (21)</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>24 (43)</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>35 (48)</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>43 (50)</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>− 10</SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>0.02</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>
                              <Emphasis Type="Bold">29</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c10">
                            <SimplePara>&lt; 0.01</SimplePara>
                          </entry>
                        </row>
                      </tbody>
                    </tgroup>
                    <tfooter>
                      <SimplePara>
                        <Emphasis Type="Italic">D</Emphasis> change, <Emphasis Type="Italic">EORTC</Emphasis> European Organisation for Research and Treatment of Cancer, <Emphasis Type="Italic">HN35</Emphasis> Head and Neck module, <Emphasis Type="Italic">IMRT</Emphasis> intensity-modulated radiation therapy, <Emphasis Type="Italic">QLQ-C30</Emphasis> Quality of Life Questionnaire Core module, <Emphasis Type="Italic">QoL</Emphasis> quality of life, <Emphasis Type="Italic">SD</Emphasis> standard deviation, <Emphasis Type="Italic">t</Emphasis> timepoint</SimplePara>
                      <SimplePara>
                        <Superscript>a</Superscript>Unadjusted means (SDs) of QoL before and after IMRT</SimplePara>
                      <SimplePara>
                        <Superscript>b</Superscript>Mean change over time (mean of individual differences between two assessment points)</SimplePara>
                      <SimplePara>
                        <Superscript>c</Superscript>
                        <Emphasis Type="Italic">P</Emphasis> value for matched signed-rank tests comparing QoL at baseline (t0) with QoL after IMRT (t1 and t4).</SimplePara>
                    </tfooter>
                  </Table>
                </Para>
                <Para>One year after IMRT, all of the C30 functioning scores were equivalent to or higher than at baseline (Table <InternalRef RefID="Tab2">2</InternalRef>). The largest improvements were observed in Social functioning (+ 12) and Global health status (+ 14). Most C30 symptom scores were lower 1 year after IMRT than at baseline, indicating better QoL; notably, Pain had decreased ( − 11). Most HN35 scores had recovered substantially (to baseline values or lower) by 1 year after IMRT (Table <InternalRef RefID="Tab2">2</InternalRef>). However, some scores remained higher than at baseline, with clinically meaningful increases still present in Senses (+ 14), Dry mouth (+ 28), and Sticky saliva (+ 15). A clinically and statistically significant improvement was seen for Felt ill (− 18).</Para>
                <Para>At the 1-year timepoint, a notable reduction was observed in the use of painkillers ( − 27 compared with baseline). A reduction in weight loss (− 43) was observed, along with a corresponding increase in weight gain (Table <InternalRef RefID="Tab2">2</InternalRef>).</Para>
              </Section2>
              <Section2 ID="Sec9">
                <Heading>Predictors of QoL changes</Heading>
                <Para>We also investigated predictors of QoL deterioration between baseline and 1 year (Table <InternalRef RefID="Tab3">3</InternalRef>). Potential predictors tested were treatment (definitive radiotherapy or chemoradiotherapy vs adjuvant radiotherapy or chemoradiotherapy) and tumor site (oral cavity vs other sites), adjusted for age.<Table Float="Yes" ID="Tab3">
                    <Caption Language="En">
                      <CaptionNumber>Table 3</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Predictors of quality of life deterioration in patients with head and neck cancer before and 1 year after intensity-modulated radiotherapy (<Emphasis Type="Italic">IMRT</Emphasis>). Values in bold are those with evidence of an effect modification of time by a predictor</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <tgroup cols="9">
                      <colspec align="left" colname="c1" colnum="1"/>
                      <colspec align="left" colname="c2" colnum="2"/>
                      <colspec align="left" colname="c3" colnum="3"/>
                      <colspec align="left" colname="c4" colnum="4"/>
                      <colspec align="left" colname="c5" colnum="5"/>
                      <colspec align="left" colname="c6" colnum="6"/>
                      <colspec align="left" colname="c7" colnum="7"/>
                      <colspec align="left" colname="c8" colnum="8"/>
                      <colspec align="left" colname="c9" colnum="9"/>
                      <thead>
                        <row>
                          <entry align="left" colname="c1"/>
                          <entry align="left" nameend="c3" namest="c2">
                            <SimplePara>Time</SimplePara>
                          </entry>
                          <entry align="left" nameend="c5" namest="c4">
                            <SimplePara>Time * oral cavity (vs other sites)</SimplePara>
                          </entry>
                          <entry align="left" nameend="c7" namest="c6">
                            <SimplePara>Time * adjuvant IMRT (vs definitive IMRT)</SimplePara>
                          </entry>
                          <entry align="left" nameend="c9" namest="c8">
                            <SimplePara>Time * age</SimplePara>
                          </entry>
                        </row>
                      </thead>
                      <tbody>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Domain</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>F<Superscript>a</Superscript>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>
                              <Emphasis Type="Italic">P</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>F<Superscript>a</Superscript>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>
                              <Emphasis Type="Italic">P</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>F<Superscript>a</Superscript>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Italic">P</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>F<Superscript>a</Superscript>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>
                              <Emphasis Type="Italic">P</Emphasis>
                            </SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Senses</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>0.1</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>0.83</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>0.9</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>0.36</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>0.1</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>0.80</SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>0.2</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>0.67</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Dry mouth</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>
                              <Emphasis Type="Bold">4.9</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>
                              <Emphasis Type="Bold">0.03</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>1.7</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>0.20</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>0.1</SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>0.83</SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>1.2</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>0.28</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Sticky saliva</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>0.2</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>0.69</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>0.7</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>0.40</SimplePara>
                          </entry>
                          <entry align="left" colname="c6">
                            <SimplePara>
                              <Emphasis Type="Bold">3.5</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c7">
                            <SimplePara>
                              <Emphasis Type="Bold">0.05</Emphasis>
                            </SimplePara>
                          </entry>
                          <entry align="left" colname="c8">
                            <SimplePara>0.1</SimplePara>
                          </entry>
                          <entry align="left" colname="c9">
                            <SimplePara>0.77</SimplePara>
                          </entry>
                        </row>
                      </tbody>
                    </tgroup>
                    <tfooter>
                      <SimplePara>
                        <Superscript>a</Superscript>F-statistics of multivariate generalized linear model analysis of variance with repeated measures.</SimplePara>
                    </tfooter>
                  </Table>
                </Para>
                <Para>Mouth dryness deteriorated in all patients, regardless of age, treatment received, and site of the tumor. Sticky saliva issues increased to a greater extent in patients with definitive versus adjuvant IMRT (F = 3.5; <Emphasis Type="Italic">P</Emphasis> = 0.05). Patients who had definitive IMRT had fewer problems with Sticky saliva before IMRT than those who had surgery before IMRT. However, 1 year after the start of therapy, patients with definitive IMRT had greater problems with Sticky saliva than those who had received adjuvant IMRT. Problems with Sticky saliva increased over time in both groups. Increases in problems with Senses, which was a significant factor in the univariate analysis (data not shown), were not confirmed in the multivariate analysis.</Para>
              </Section2>
              <Section2 ID="Sec10">
                <Heading>Nutrition</Heading>
                <Para>The patients’ average body mass index (BMI) decreased from 25.1 kg/m<Superscript>2</Superscript> at baseline to 23.5 kg/m<Superscript>2</Superscript> at the end of IMRT, and further decreased to 22.8 kg/m<Superscript>2</Superscript> at 3 and 6 months after IMRT. By 1 year post-IMRT, mean BMI had increased to 23.3 kg/m<Superscript>2</Superscript>.</Para>
                <Para>The proportion of patients with a percutaneous endoscopic gastrostomy (PEG) tube increased from 42 % at baseline to 75 % at the end of treatment. From 6 weeks after IMRT onwards, the proportion of patients with a PEG tube decreased slowly but steadily from 68 % after 6–8 weeks, to 42 % after 6 months, and 31 % after 1 year.</Para>
                <Para>Parenteral nutrition was rarely needed. Before treatment, one patient (0.9 %) used parenteral nutrition; this increased to 7 % (<Emphasis Type="Italic">n</Emphasis> = 8) at the end of IMRT, then decreased to 4 % (<Emphasis Type="Italic">n</Emphasis> = 5) at 6–8 weeks after IMRT, 3 % (<Emphasis Type="Italic">n</Emphasis> = 3) at 6 months after IMRT, and 0.9 % (<Emphasis Type="Italic">n</Emphasis> = 1) by 1 year after IMRT.</Para>
              </Section2>
              <Section2 ID="Sec11">
                <Heading>Toxicity</Heading>
                <Para>Dysphagia, as assessed by the radiation oncologist, was common at the end of IMRT; over 40 % of patients had grade 3 dysphagia at this time, and although this decreased over time, 11 % of patients still had grade 3 symptoms after 1 year (Fig. <InternalRef RefID="Fig2">2</InternalRef>). Physician-assessed xerostomia also peaked at the end of IMRT and declined thereafter, with 14 % of patients having grade 2 xerostomia 1 year after IMRT. Grade 2/3 mucositis was also common at the end of treatment but was negligible by the 1-year time point.<Figure Category="Standard" Float="Yes" ID="Fig2">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 2</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Incidence of selected adverse events before, during, and after intensity-modulated radiotherapy in patients with head and neck cancer. Adverse events assessed by the radiation oncologist using Radiation Therapy Oncology Group toxicity criteria. (<Emphasis Type="Italic">RT</Emphasis> radiotherapy)</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO2">
                      <ImageObject Color="BlackWhite" FileRef="MediaObjects/66_2015_824_Fig2_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
                    </MediaObject>
                  </Figure>
                </Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec12">
              <Heading>Discussion</Heading>
              <Para>This longitudinal analysis of patients undergoing IMRT for the treatment of HNC has demonstrated that patients experience significant deterioration of their QoL during IMRT. Some important QoL areas improve considerably by 1 year after treatment, although others remain compromised. This is in line with previous reports that rehabilitation after multimodal treatment for HNC can take a year or more [<CitationRef CitationID="CR9">9</CitationRef>].</Para>
              <Para>Pain, Social functioning, and Global health status improved to a clinically meaningful extent when assessed 1 year after the end of treatment compared with baseline, indicating that patients were generally feeling better and more at ease in social situations than they had been before the start of treatment. Similar patterns of recovery of Global Health Status after treatment have been reported in some studies [<CitationRef CitationID="CR17">17</CitationRef>–<CitationRef CitationID="CR19">19</CitationRef>]; others, in contrast, observed no change compared with baseline in Global Health Status at 1 year [<CitationRef CitationID="CR20">20</CitationRef>], suggesting that this measure is dependent on a number of factors, including baseline scores and complexity of treatment.</Para>
              <Para>In contrast, the scores for the HNC-specific domains Senses (problems with sense of taste or smell), Dry mouth, and Sticky saliva were all still clinically meaningfully worse than their baseline levels 1 year after IMRT, although scores had recovered from the peaks observed at the end of IMRT. Similar results have been reported from other studies [<CitationRef CitationID="CR17">17</CitationRef>, <CitationRef CitationID="CR19">19</CitationRef>, <CitationRef CitationID="CR20">20</CitationRef>], clearly demonstrating that recovery from dry mouth is slower than other adverse effects of treatment. In their systematic review of 37 QoL studies in patients with HNC, So et al. [<CitationRef CitationID="CR21">21</CitationRef>] reported that problems with Dry mouth, Sticky saliva, and Fatigue were most often compromised 1 year after therapy. Indeed, several longer-term QoL studies of patients undergoing treatment for HNC showed that Senses, Dry mouth, and Sticky saliva scores had not returned to baseline 5 years after treatment [<CitationRef CitationID="CR18">18</CitationRef>, <CitationRef CitationID="CR22">22</CitationRef>, <CitationRef CitationID="CR23">23</CitationRef>]. Oskam et al. [<CitationRef CitationID="CR24">24</CitationRef>] did not observe a return to baseline values in their long-term (96–131 months) assessment of patients with oral and oropharyngeal cancers, which suggests that these aspects may never return to pretreatment levels. Further assessment of our patients beyond 1 year will provide additional information.</Para>
              <Para>Physical problems were apparently ongoing in the present study after 1 year, as demonstrated by the incidences of oncologist-assessed RTOG xerostomia and dysphagia and the patient-reported Dry mouth and Sticky saliva scores observed at the end of the study. One might thus expect that Global Health Status scores would remain compromised throughout the observation period, particularly as both xerostomia [<CitationRef CitationID="CR25">25</CitationRef>] and dysphagia [<CitationRef CitationID="CR26">26</CitationRef>, <CitationRef CitationID="CR27">27</CitationRef>] have been shown to correlate with QoL in previous studies. The fact that this was not the case suggests that the effect of xerostomia on global QoL is relatively limited in the absence of acute mucositis [<CitationRef CitationID="CR28">28</CitationRef>]. Another possible explanation is that patients mentally adjust to their disease, resulting in a better overall judgment of their life in general, even when some QoL aspects are still impaired. For example, Morton [<CitationRef CitationID="CR29">29</CitationRef>] reported adaptation to dysfunction in a retrospective analysis of QoL in patients with HNC, as demonstrated by scores for perceived difficulty in swallowing, which decreased despite an ongoing need for a soft or liquid diet.</Para>
              <Para>Clinically meaningful improvements compared with baseline were recorded at 1 year in objective HNC-specific considerations including feeling ill, using painkillers, and gaining weight. Mean BMI values fell during IMRT, but had started to recover in the 6–12 months posttreatment. These findings support the suggestion that patients genuinely feel better after the immediate effects of therapy have abated and that xerostomia-related issues do not detract from their general well-being in the longer term. Pow et al. [<CitationRef CitationID="CR17">17</CitationRef>] also reported an increased proportion of patients with weight gain 1 year after IMRT, but no overall reduction in the use of painkillers.</Para>
              <Para>After 1 year, the incidence of sticky saliva and dry mouth in our study was greater among patients treated with definitive chemoradiotherapy than in those who had adjuvant chemoradiotherapy, despite the opposite having been the case before treatment. This may be related to the fact that in the absence of tumor less volume was irradiated to a higher dose or because parotid sparing was more likely to be a feasible option. Alternatively, it may be related to the small size of the definitive chemoradiotherapy group compared with the adjuvant group. Further studies are required to establish whether this is a true effect or a chance finding.</Para>
              <Para>The relationship between QoL and xerostomia underlines the importance of minimizing side effects during treatment by sparing the salivary glands where possible. A focus of treatment planning has been to spare the parotid and submandibular glands and oral cavity, which was shown to significantly reduce the incidence of both xerostomia and dysphagia [<CitationRef CitationID="CR7">7</CitationRef>, <CitationRef CitationID="CR30">30</CitationRef>, <CitationRef CitationID="CR31">31</CitationRef>]. Xerostomia continues to be a problem. Better strategies for its prevention and treatment are clearly needed. Measures investigated to date have included submandibular gland transfer [<CitationRef CitationID="CR32">32</CitationRef>], amifostine [<CitationRef CitationID="CR33">33</CitationRef>], pilocarpine [<CitationRef CitationID="CR34">34</CitationRef>], and acupuncture [<CitationRef CitationID="CR35">35</CitationRef>, <CitationRef CitationID="CR37">37</CitationRef>]. To date, there is no strong evidence that these interventions significantly improve saliva flow or dry mouth symptoms [<CitationRef CitationID="CR37">37</CitationRef>, <CitationRef CitationID="CR38">38</CitationRef>].</Para>
              <Para>One of the strengths of this study was that few patients were lost to follow-up, strengthening the conclusions drawn from the data. Observational studies, while less rigorously controlled than randomized clinical trials, have the advantage of more accurately reflecting the real-life clinical situation because they suffer less frequently from selection bias that can result from excluding patients based on factors such as comorbidity and age.</Para>
            </Section1>
            <Section1 ID="Sec13">
              <Heading>Conclusion</Heading>
              <Para>This analysis has demonstrated that LAHNC patients treated with IMRT and their health care providers can expect that most aspects of QoL will substantially recover within a year of treatment. Xerostomia-related issues appear to persist at this time point but do not impact on overall QoL. Patients should be counseled at the start of therapy to reduce disappointment in the pace of recovery with its potentially negative impact on QoL.</Para>
            </Section1>
          </Body>
          <BodyRef FileRef="BodyRef/PDF/66_2015_Article_824.pdf" OutputMedium="All" PDFType="Typeset" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Ethics>
              <Heading>Compliance with ethical guidelines</Heading>
              <FormalPara RenderingStyle="Style1">
                <Heading>Conflict of interest</Heading>
                <Para>S. Tribius, M. Raguse, C. Voigt, A. Münscher, A. Gröbe, C. Petersen, A. Krüll, C. Bergellt and S. Singer state that there are no conflicts of interest.</Para>
              </FormalPara>
              <SimplePara>All studies on humans described in the present manuscript were carried out with the approval of the responsible ethics committee and in accordance with national law and the Helsinki Declaration of 1975 (in its current, revised form). Informed consent was obtained from all patients included in studies</SimplePara>
            </Ethics>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1</CitationNumber>
                <BibUnstructured>Grégoire V, Lefebvre JL, Licitra L, Felip E, on behalf of the EHNS-ESMO-ESTRO Guidelines Working Group (2010) Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v184–v186</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2</CitationNumber>
                <BibUnstructured>National Comprehensive Cancer Network (2014) Clinical practice guidelines in oncology. Head and neck cancers version 2.2014. <ExternalRef>
                    <RefSource>https://www.nccn.org/store/login/login.aspx?ReturnURL</RefSource>
                    <RefTarget Address="https://www.nccn.org/store/login/login.aspx?ReturnURL" TargetType="URL"/>
                  </ExternalRef> = <ExternalRef>
                    <RefSource>http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf</RefSource>
                    <RefTarget Address="http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf" TargetType="URL"/>
                  </ExternalRef>. Accessed 1 July 2014</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Trotti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TF</Initials>
                    <FamilyName>Pajak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CK</Initials>
                    <FamilyName>Gwede</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Paulus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Cooper</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Forastiere</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Ridge</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Watkins-Bruner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AS</Initials>
                    <FamilyName>Garden</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KK</Initials>
                    <FamilyName>Ang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Curran</FamilyName>
                  </BibAuthorName>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group</ArticleTitle>
                  <JournalTitle>Lancet Oncol</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>613</FirstPage>
                  <LastPage>624</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1470-2045(07)70144-4</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>17543584</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Trotti A, Pajak TF, Gwede CK, Paulus R, Cooper J, Forastiere A, Ridge JA, Watkins-Bruner D, Garden AS, Ang KK, Curran W (2007) TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol 8:613–624</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Hörmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Sadick</FamilyName>
                  </BibAuthorName>
                  <Year>2013</Year>
                  <ArticleTitle Language="En">Role of surgery in the management of head and neck cancer: a contemporary view of the data in the era of organ preservation</ArticleTitle>
                  <JournalTitle>J Laryngol Otol</JournalTitle>
                  <VolumeID>127</VolumeID>
                  <FirstPage>121</FirstPage>
                  <LastPage>127</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1017/S0022215112002988</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>23298649</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hörmann K, Sadick H (2013) Role of surgery in the management of head and neck cancer: a contemporary view of the data in the era of organ preservation. J Laryngol Otol 127:121–127</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Bhide</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Nutting</FamilyName>
                  </BibAuthorName>
                  <Year>2010</Year>
                  <ArticleTitle Language="En">Advances in radiotherapy for head and neck cancer</ArticleTitle>
                  <JournalTitle>Oral Oncol</JournalTitle>
                  <VolumeID>46</VolumeID>
                  <FirstPage>439</FirstPage>
                  <LastPage>441</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.oraloncology.2010.03.005</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BC3cvksFOqsw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>20409746</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bhide SA, Nutting CM (2010) Advances in radiotherapy for head and neck cancer. Oral Oncol 46:439–441</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SB</Initials>
                    <FamilyName>Jensen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Pedersen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Reibel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Nauntofte</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Xerostomia and hypofunction of the salivary glands in cancer therapy</ArticleTitle>
                  <JournalTitle>Support Care Cancer</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>207</FirstPage>
                  <LastPage>225</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12673459</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jensen SB, Pedersen AM, Reibel J, Nauntofte B (2003) Xerostomia and hypofunction of the salivary glands in cancer therapy. Support Care Cancer 11:207–225</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Tribius</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Sommer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Prosch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Bajrovic</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Muenscher</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Blessmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Kruell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Pertsen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Todorovic</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Tennstedt</FamilyName>
                  </BibAuthorName>
                  <Year>2013</Year>
                  <ArticleTitle Language="En">Xerostomia after radiotherapy. What matters—mean total dose or dose to each parotid gland</ArticleTitle>
                  <JournalTitle>Strahlenther Onkol</JournalTitle>
                  <VolumeID>189</VolumeID>
                  <FirstPage>216</FirstPage>
                  <LastPage>222</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s00066-012-0257-2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BC3szivFSgtA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>23354440</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Tribius S, Sommer J, Prosch C, Bajrovic A, Muenscher A, Blessmann M, Kruell A, Pertsen C, Todorovic M, Tennstedt P (2013) Xerostomia after radiotherapy. What matters—mean total dose or dose to each parotid gland. Strahlenther Onkol 189:216–222</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PM</Initials>
                    <FamilyName>Harari</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Promising new advances in head and neck radiotherapy</ArticleTitle>
                  <JournalTitle>Ann Oncol</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <IssueID>6</IssueID>
                  <FirstPage>vi13</FirstPage>
                  <LastPage>vi19</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15987991</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Harari PM (2005) Promising new advances in head and neck radiotherapy. Ann Oncol 16 (Suppl 6):vi13–vi19</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Veldeman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Madani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Hulstaert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>De Meerleer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Mareel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>De Neve</FamilyName>
                  </BibAuthorName>
                  <Year>2008</Year>
                  <ArticleTitle Language="En">Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies</ArticleTitle>
                  <JournalTitle>Lancet Oncol</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>367</FirstPage>
                  <LastPage>375</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1470-2045(08)70098-6</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>18374290</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Veldeman L, Madani I, Hulstaert F, De Meerleer G, Mareel M, De Neve W (2008) Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol 9:367–375</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JS</Initials>
                    <FamilyName>Cooper</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TF</Initials>
                    <FamilyName>Pajak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Forastiere</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Jacobs</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BH</Initials>
                    <FamilyName>Campbell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SB</Initials>
                    <FamilyName>Saxman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Kish</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HE</Initials>
                    <FamilyName>Kim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Cmelak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Rotman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Machtay</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JF</Initials>
                    <FamilyName>Ensley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KS</Initials>
                    <FamilyName>Chao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Schultz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KK</Initials>
                    <FamilyName>Fu</FamilyName>
                  </BibAuthorName>
                  <InstitutionalAuthorName>Radiation Therapy Oncology Group 9501/Intergroup</InstitutionalAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En"> Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck</ArticleTitle>
                  <JournalTitle>N Engl J Med</JournalTitle>
                  <VolumeID>350</VolumeID>
                  <FirstPage>1937</FirstPage>
                  <LastPage>1944</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1056/NEJMoa032646</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>15128893</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KS, Schultz CJ, Lee N, Fu KK, Radiation Therapy Oncology Group 9501/Intergroup (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Bernier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Domenge</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Ozsahin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Matuszewska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Lefèbvre</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RH</Initials>
                    <FamilyName>Greiner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Giralt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Maingon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Rolland</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bolla</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Cognetti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Bourhis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Kirkpatrick</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Glabbeke</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <InstitutionalAuthorName>European Organization for Research and Treatment of Cancer Trial 22931</InstitutionalAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer</ArticleTitle>
                  <JournalTitle>N Engl J Med</JournalTitle>
                  <VolumeID>350</VolumeID>
                  <FirstPage>1945</FirstPage>
                  <LastPage>1952</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1056/NEJMoa032641</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjslehsrk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>15128894</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick A, van Glabbeke M, European Organization for Research and Treatment of Cancer Trial 22931 (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Bjordal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Graeff</FamilyName>
                    <Particle>de</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PM</Initials>
                    <FamilyName>Fayers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Hammerlid</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Pottelsberghe</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Curran</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Ahlner-Elmqvist</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EJ</Initials>
                    <FamilyName>Maher</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Meyza</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Brédart</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AL</Initials>
                    <FamilyName>Söderholm</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JJ</Initials>
                    <FamilyName>Arraras</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JS</Initials>
                    <FamilyName>Feine</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Abendstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RP</Initials>
                    <FamilyName>Morton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Pignon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Huguenin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Bottomly</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Kaasa</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H &amp; N35) in head and neck patients. EORTC Quality of Life Group</ArticleTitle>
                  <JournalTitle>Eur J Cancer</JournalTitle>
                  <VolumeID>36</VolumeID>
                  <FirstPage>1796</FirstPage>
                  <LastPage>1807</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0959-8049(00)00186-6</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3M%2FltFSmsQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>10974628</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bjordal K, de Graeff A, Fayers PM, Hammerlid E, van Pottelsberghe C, Curran D, Ahlner-Elmqvist M, Maher EJ, Meyza JW, Brédart A, Söderholm AL, Arraras JJ, Feine JS, Abendstein H, Morton RP, Pignon T, Huguenin P, Bottomly A, Kaasa S (2000) A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H &amp; N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 36:1796–1807</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MT</Initials>
                    <FamilyName>King</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30</ArticleTitle>
                  <JournalTitle>Qual Life Res</JournalTitle>
                  <VolumeID>5</VolumeID>
                  <FirstPage>555</FirstPage>
                  <LastPage>567</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF00439229</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2s7ks1Wrsw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>8993101</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>King MT (1996) The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 5:555–567</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Singer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Wollbrück</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Wulke</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2009</Year>
                  <ArticleTitle Language="En">Validation of the EORTC QLQ-C30 and EORTC QLQ-H &amp; N35 in laryngeal cancer patients after surgery</ArticleTitle>
                  <JournalTitle>Head Neck</JournalTitle>
                  <VolumeID>31</VolumeID>
                  <FirstPage>64</FirstPage>
                  <LastPage>76</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/hed.20938</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>18972411</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Singer S, Wollbrück D, Wulke C et al (2009) Validation of the EORTC QLQ-C30 and EORTC QLQ-H &amp; N35 in laryngeal cancer patients after surgery. Head Neck 31:64–76</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Singer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Arraras</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WC</Initials>
                    <FamilyName>Chie</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Fisher</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Galalae</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Hammerlid</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Nicolatou-Galitis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Schmalz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IM</Initials>
                    <FamilyName>Verdonck-de Leeuw</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Gamper</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Keszte</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Hofmeister</FamilyName>
                  </BibAuthorName>
                  <Year>2013</Year>
                  <ArticleTitle Language="En">Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H &amp; N35: a methodological review</ArticleTitle>
                  <JournalTitle>Qual Life Res</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>1927</FirstPage>
                  <LastPage>1941</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s11136-012-0325-1</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>23188134</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Singer S, Arraras J, Chie WC, Fisher S, Galalae R, Hammerlid E, Nicolatou-Galitis O, Schmalz C, Verdonck-de Leeuw IM, Gamper E, Keszte J, Hofmeister D (2013) Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H &amp; N35: a methodological review. Qual Life Res 22:1927–1941</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16</CitationNumber>
                <BibUnstructured>Fayers PM, Aaronson NK, Bjordal K et al (2001) The EORTC QLQ-C30 Scoring Manual, 3rd edn. European Organisation for Research and Treatment of Cancer, Brussels</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EH</Initials>
                    <FamilyName>Pow</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DL</Initials>
                    <FamilyName>Kwong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AS</Initials>
                    <FamilyName>McMillan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MC</Initials>
                    <FamilyName>Wong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JS</Initials>
                    <FamilyName>Sham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LH</Initials>
                    <FamilyName>Leung</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WK</Initials>
                    <FamilyName>Leung</FamilyName>
                  </BibAuthorName>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>66</VolumeID>
                  <FirstPage>981</FirstPage>
                  <LastPage>991</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ijrobp.2006.06.013</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>17145528</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, Leung WK (2006) Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66:981–991</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PM</Initials>
                    <FamilyName>Braam</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Roesink</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CP</Initials>
                    <FamilyName>Raaijmakers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WB</Initials>
                    <FamilyName>Busschers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CH</Initials>
                    <FamilyName>Terhaard</FamilyName>
                  </BibAuthorName>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy</ArticleTitle>
                  <JournalTitle>Radiat Oncol</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>3</FirstPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1186/1748-717X-2-3</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>1779273</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>17207274</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Braam PM, Roesink JM, Raaijmakers CP, Busschers WB, Terhaard CH (2007) Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy. Radiat Oncol 2:3</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>FM</Initials>
                    <FamilyName>Fang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CY</Initials>
                    <FamilyName>Chien</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WL</Initials>
                    <FamilyName>Tsai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HC</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HC</Initials>
                    <FamilyName>Hsu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CC</Initials>
                    <FamilyName>Lui</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TL</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HY</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibAuthorName>
                  <Year>2008</Year>
                  <ArticleTitle Language="En">Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy—a longitudinal study</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>72</VolumeID>
                  <FirstPage>356</FirstPage>
                  <LastPage>364</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ijrobp.2007.12.054</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>18355980</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fang FM, Chien CY, Tsai WL, Chen HC, Hsu HC, Lui CC, Huang TL, Huang HY (2008) Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy—a longitudinal study. Int J Radiat Oncol Biol Phys 72:356–364</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Nutting</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Morden</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Harrington</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TG</Initials>
                    <FamilyName>Urbano</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Bhide</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Clark</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EA</Initials>
                    <FamilyName>Miles</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AB</Initials>
                    <FamilyName>Miah</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Newbold</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Tanay</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Adab</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SJ</Initials>
                    <FamilyName>Jefferies</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Scrase</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BK</Initials>
                    <FamilyName>Yap</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RP</Initials>
                    <FamilyName>A’Hern</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Sydenham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Emson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Hall</FamilyName>
                  </BibAuthorName>
                  <InstitutionalAuthorName>PARSPORT trial management group</InstitutionalAuthorName>
                  <Year>2011</Year>
                  <ArticleTitle Language="En">Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial</ArticleTitle>
                  <JournalTitle>Lancet Oncol</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>127</FirstPage>
                  <LastPage>136</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1470-2045(10)70290-4</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3033533</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>21236730</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A’Hern RP, Sydenham MA, Emson M, Hall E, PARSPORT trial management group (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12:127–136</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>WK</Initials>
                    <FamilyName>So</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Chan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DN</Initials>
                    <FamilyName>Chan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BG</Initials>
                    <FamilyName>Hughes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SY</Initials>
                    <FamilyName>Chair</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KC</Initials>
                    <FamilyName>Choi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CW</Initials>
                    <FamilyName>Chan</FamilyName>
                  </BibAuthorName>
                  <Year>2012</Year>
                  <ArticleTitle Language="En">Quality-of-life among head and neck cancer survivors at one year after treatment—a systematic review</ArticleTitle>
                  <JournalTitle>Eur J Cancer</JournalTitle>
                  <VolumeID>48</VolumeID>
                  <FirstPage>2391</FirstPage>
                  <LastPage>2408</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ejca.2012.04.005</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BC38nisFGjsw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>22579456</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>So WK, Chan RJ, Chan DN, Hughes BG, Chair SY, Choi KC, Chan CW (2012) Quality-of-life among head and neck cancer survivors at one year after treatment—a systematic review. Eur J Cancer:48:2391–2408</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Abendstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Nordgren</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Boysen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Jannert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Silander</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Ahlner-Elmqvist</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Hammerlid</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Bjordal</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Quality of life and head and neck cancer: a 5 year prospective study</ArticleTitle>
                  <JournalTitle>Laryngoscope</JournalTitle>
                  <VolumeID>115</VolumeID>
                  <FirstPage>2183</FirstPage>
                  <LastPage>2192</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/01.MLG.0000181507.69620.14</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>16369164</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Abendstein H, Nordgren M, Boysen M, Jannert M, Silander E, Ahlner-Elmqvist M, Hammerlid E, Bjordal K (2005) Quality of life and head and neck cancer: a 5 year prospective study. Laryngoscope 115:2183–2192</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Nordgren</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Hammerlid</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Bjordal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Ahlner-Elmqvist</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Boysen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Jannert</FamilyName>
                  </BibAuthorName>
                  <Year>2008</Year>
                  <ArticleTitle Language="En">Quality of life in oral carcinoma: a 5-year prospective study</ArticleTitle>
                  <JournalTitle>Head Neck</JournalTitle>
                  <VolumeID>30</VolumeID>
                  <FirstPage>461</FirstPage>
                  <LastPage>470</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/hed.20735</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>18098303</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nordgren M, Hammerlid E, Bjordal K, Ahlner-Elmqvist M, Boysen M, Jannert M (2008) Quality of life in oral carcinoma: a 5-year prospective study. Head Neck 30:461–470</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>IM</Initials>
                    <FamilyName>Oskam</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IM</Initials>
                    <FamilyName>Verdonck-de Leeuw</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NK</Initials>
                    <FamilyName>Aaronson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BI</Initials>
                    <FamilyName>Witte</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Bree</FamilyName>
                    <Particle>de</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Doornaert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Langendijk</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CR</Initials>
                    <FamilyName>Leemans</FamilyName>
                  </BibAuthorName>
                  <Year>2013</Year>
                  <ArticleTitle Language="En">Prospective evaluation of health-related quality of life in long-term oral and oropharyngeal cancer survivors and the perceived need for supportive care</ArticleTitle>
                  <JournalTitle>Oral Oncol</JournalTitle>
                  <VolumeID>49</VolumeID>
                  <FirstPage>443</FirstPage>
                  <LastPage>448</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.oraloncology.2012.12.005</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>23318122</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Oskam IM, Verdonck-de Leeuw IM, Aaronson NK, Witte BI, de Bree R, Doornaert P, Langendijk JA, Leemans CR (2013) Prospective evaluation of health-related quality of life in long-term oral and oropharyngeal cancer survivors and the perceived need for supportive care. Oral Oncol 49:443–448</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Lin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HM</Initials>
                    <FamilyName>Kim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Terrell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Dawson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Ship</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Eisbruch</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>57</VolumeID>
                  <FirstPage>61</FirstPage>
                  <LastPage>70</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0360-3016(03)00361-4</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>12909216</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A (2003) Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 57:61–70</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Maurer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hipp</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Schäfer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Kölbl</FamilyName>
                  </BibAuthorName>
                  <Year>2011</Year>
                  <ArticleTitle Language="En">Dysphagia. Impact on quality of life after radio(chemo)therapy of head and neck cancer</ArticleTitle>
                  <JournalTitle>Strahlenther Onkol</JournalTitle>
                  <VolumeID>187</VolumeID>
                  <FirstPage>744</FirstPage>
                  <LastPage>749</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s00066-011-2275-x</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>22037655</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Maurer J, Hipp M, Schäfer C, Kölbl O (2011) Dysphagia. Impact on quality of life after radio(chemo)therapy of head and neck cancer. Strahlenther Onkol 187:744–749</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KU</Initials>
                    <FamilyName>Hunter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Schipper</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FY</Initials>
                    <FamilyName>Feng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Lyden</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Haxer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CA</Initials>
                    <FamilyName>Murdoch-Kinch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Cornwall</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CS</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DB</Initials>
                    <FamilyName>Chepeha</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Eisbruch</FamilyName>
                  </BibAuthorName>
                  <Year>2013</Year>
                  <ArticleTitle Language="En">Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>85</VolumeID>
                  <FirstPage>935</FirstPage>
                  <LastPage>940</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ijrobp.2012.08.030</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3556374</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>23040224</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hunter KU, Schipper M, Feng FY, Lyden T, Haxer M, Murdoch-Kinch CA, Cornwall B, Lee CS, Chepeha DB, Eisbruch A (2013) Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes. Int J Radiat Oncol Biol Phys 85:935–940</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Ringash</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Warde</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Lockwood</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>O’Sullivan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Waldron</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Cummings</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>61</VolumeID>
                  <FirstPage>1403</FirstPage>
                  <LastPage>1407</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ijrobp.2004.08.001</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>15817343</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ringash J, Warde P, Lockwood G, O’Sullivan B, Waldron J, Cummings B (2005) Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int J Radiat Oncol Biol Phys 61:1403–1407</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RP</Initials>
                    <FamilyName>Morton</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Studies in the quality of life of head and neck cancer patients: results of a two-year longitudinal study and a comparative cross-sectional cross-cultural survey</ArticleTitle>
                  <JournalTitle>Laryngoscope</JournalTitle>
                  <VolumeID>113</VolumeID>
                  <FirstPage>1091</FirstPage>
                  <LastPage>1103</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00005537-200307000-00001</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>12838004</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Morton RP (2003) Studies in the quality of life of head and neck cancer patients: results of a two-year longitudinal study and a comparative cross-sectional cross-cultural survey. Laryngoscope 113:1091–1103</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Voordeckers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Everaert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Tournel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Verellen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Baron</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Esch</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Vanhove</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Storme</FamilyName>
                  </BibAuthorName>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">Longitudinal assessment of parotid function in patients receiving tomotherapy for head and neck cancer</ArticleTitle>
                  <JournalTitle>Strahlenther Onkol</JournalTitle>
                  <VolumeID>184</VolumeID>
                  <FirstPage>400</FirstPage>
                  <LastPage>405</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s00066-008-1836-0</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Voordeckers M, Everaert H, Tournel K, Verellen D, Baron I, van Esch G, Vanhove C, Storme G (2007) Longitudinal assessment of parotid function in patients receiving tomotherapy for head and neck cancer. Strahlenther Onkol 184:400–405</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Little</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Schipper</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FY</Initials>
                    <FamilyName>Feng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Vineberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Cornwall</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CA</Initials>
                    <FamilyName>Murdoch-Kinch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Eisbruch</FamilyName>
                  </BibAuthorName>
                  <Year>2012</Year>
                  <ArticleTitle Language="En">Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>83</VolumeID>
                  <FirstPage>1007</FirstPage>
                  <LastPage>1014</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ijrobp.2011.09.004</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3288420</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>22056067</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Little M, Schipper M, Feng FY, Vineberg K, Cornwall C, Murdoch-Kinch CA, Eisbruch A (2012) Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands. Int J Radiat Oncol Biol Phys 83:1007–1014</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>32</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Jha</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Harris</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Seikaly</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Jacobs</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>McEwan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KT</Initials>
                    <FamilyName>Robbins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Grecula</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AK</Initials>
                    <FamilyName>Sharma</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KK</Initials>
                    <FamilyName>Ang</FamilyName>
                  </BibAuthorName>
                  <Year>2012</Year>
                  <ArticleTitle Language="En">A phase II study of submandibular gland transfer prior to radiation for prevention of radiation-induced xerostomia in head-and-neck cancer</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>84</VolumeID>
                  <FirstPage>437</FirstPage>
                  <LastPage>442</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ijrobp.2012.02.034</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>22541957</Handle>
                  </Occurrence>
                  <BibComments>(RTOG 0244)</BibComments>
                </BibArticle>
                <BibUnstructured>Jha N, Harris J, Seikaly H, Jacobs JR, McEwan AJ, Robbins KT, Grecula J, Sharma AK, Ang KK (2012) A phase II study of submandibular gland transfer prior to radiation for prevention of radiation-induced xerostomia in head-and-neck cancer (RTOG 0244). Int J Radiat Oncol Biol Phys 84:437–442</BibUnstructured>
              </Citation>
              <Citation ID="CR33">
                <CitationNumber>33</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TH</Initials>
                    <FamilyName>Wasserman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DM</Initials>
                    <FamilyName>Brizel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Henke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Monnier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Eschwege</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Sauer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Strnad</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and-neck cancer: 2-year follow-up of a prospective, randomized, phase III trial</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>63</VolumeID>
                  <FirstPage>985</FirstPage>
                  <LastPage>990</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ijrobp.2005.07.966</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtFKhsL3L</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>16253773</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wasserman TH, Brizel DM, Henke M, Monnier A, Eschwege F, Sauer R, Strnad V (2005) Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and-neck cancer: 2-year follow-up of a prospective, randomized, phase III trial. Int J Radiat Oncol Biol Phys 63:985–990</BibUnstructured>
              </Citation>
              <Citation ID="CR34">
                <CitationNumber>34</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Z</Initials>
                    <FamilyName>Nyarady</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Nemeth</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ban</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Mukics</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Nyarady</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Ember</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Olasz</FamilyName>
                  </BibAuthorName>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer</ArticleTitle>
                  <JournalTitle>Anticancer Res</JournalTitle>
                  <VolumeID>26</VolumeID>
                  <FirstPage>1557</FirstPage>
                  <LastPage>1562</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD28XktVGqsrs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>16619571</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nyarady Z, Nemeth A, Ban A, Mukics A, Nyarady J, Ember I, Olasz L (2006) A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer. Anticancer Res 26:1557–1562</BibUnstructured>
              </Citation>
              <Citation ID="CR35">
                <CitationNumber>35</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Simcock</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Fallowfield</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Monson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Solis-Trapala</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Parlour</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Langridge</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Jenkins</FamilyName>
                  </BibAuthorName>
                  <InstitutionalAuthorName>ARIX Steering Committee</InstitutionalAuthorName>
                  <Year>2013</Year>
                  <ArticleTitle Language="En">ARIX: a randomised trial of acupuncture v oral care sessions in patients with chronic xerostomia following treatment of head and neck cancer</ArticleTitle>
                  <JournalTitle>Ann Oncol</JournalTitle>
                  <VolumeID>24</VolumeID>
                  <FirstPage>776</FirstPage>
                  <LastPage>783</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/annonc/mds515</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BC3s%2FoslehtA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>23104718</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Simcock R, Fallowfield L, Monson K, Solis-Trapala I, Parlour L, Langridge C, Jenkins V, ARIX Steering Committee (2013) ARIX: a randomised trial of acupuncture v oral care sessions in patients with chronic xerostomia following treatment of head and neck cancer. Ann Oncol 24:776–783</BibUnstructured>
              </Citation>
              <Citation ID="CR36">
                <CitationNumber>36</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Z</Initials>
                    <FamilyName>Meng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Kay Garcia</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Hu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Chiang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Chambers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DI</Initials>
                    <FamilyName>Rosenthal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Peng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Wu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Q</Initials>
                    <FamilyName>Zhao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Zhao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Liu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Spelman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lynn Palmer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Q</Initials>
                    <FamilyName>Wei</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Cohen</FamilyName>
                  </BibAuthorName>
                  <Year>2012</Year>
                  <ArticleTitle Language="En">Sham-controlled, randomised, feasibility trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma</ArticleTitle>
                  <JournalTitle>Eur J Cancer</JournalTitle>
                  <VolumeID>48</VolumeID>
                  <FirstPage>1692</FirstPage>
                  <LastPage>1699</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ejca.2011.12.030</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>22285177</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Meng Z, Kay Garcia M, Hu C, Chiang J, Chambers M, Rosenthal DI, Peng H, Wu C, Zhao Q, Zhao G, Liu L, Spelman A, Lynn Palmer J, Wei Q, Cohen L (2012) Sham-controlled, randomised, feasibility trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma. Eur J Cancer 48:1692–1699</BibUnstructured>
              </Citation>
              <Citation ID="CR37">
                <CitationNumber>37</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Furness</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Bryan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>McMillan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Birchenough</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HV</Initials>
                    <FamilyName>Worthington</FamilyName>
                  </BibAuthorName>
                  <Year>2013</Year>
                  <ArticleTitle Language="En">Interventions for the management of dry mouth: non-pharmacological interventions</ArticleTitle>
                  <JournalTitle>Cochrane Database Syst Rev</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>CD009603</FirstPage>
                  <Occurrence Type="PID">
                    <Handle>23996155</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Furness S, Bryan G, McMillan R, Birchenough S, Worthington HV (2013) Interventions for the management of dry mouth: non-pharmacological interventions. Cochrane Database Syst Rev 8:CD009603</BibUnstructured>
              </Citation>
              <Citation ID="CR38">
                <CitationNumber>38</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Furness</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HV</Initials>
                    <FamilyName>Worthington</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Bryan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Birchenough</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>McMillan</FamilyName>
                  </BibAuthorName>
                  <Year>2011</Year>
                  <ArticleTitle Language="En">Interventions for the management of dry mouth: topical therapies</ArticleTitle>
                  <JournalTitle>Cochrane Database Syst Rev</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>CD008934</FirstPage>
                  <Occurrence Type="PID">
                    <Handle>22161442</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Furness S, Worthington HV, Bryan G, Birchenough S, McMillan R (2011) Interventions for the management of dry mouth: topical therapies. Cochrane Database Syst Rev 12:CD008934</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
